122 related articles for article (PubMed ID: 33992624)
21. Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-β Dependent Hepatic Stellate Cell Activation and Liver Fibrosis.
Martin-Mateos R; De Assuncao TM; Arab JP; Jalan-Sakrikar N; Yaqoob U; Greuter T; Verma VK; Mathison AJ; Cao S; Lomberk G; Mathurin P; Urrutia R; Huebert RC; Shah VH
Cell Mol Gastroenterol Hepatol; 2019; 7(1):197-209. PubMed ID: 30539787
[TBL] [Abstract][Full Text] [Related]
22. Blockade of enhancer of zeste homolog 2 alleviates renal injury associated with hyperuricemia.
Shi Y; Xu L; Tao M; Fang L; Lu J; Gu H; Ma S; Lin T; Wang Y; Bao W; Qiu A; Zhuang S; Liu N
Am J Physiol Renal Physiol; 2019 Mar; 316(3):F488-F505. PubMed ID: 30566000
[TBL] [Abstract][Full Text] [Related]
23. NF-κB mediates the survival of corneal myofibroblast induced by angiotensin II.
Pan HW; Cui YH; Zeng JW
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4220-8. PubMed ID: 24917146
[TBL] [Abstract][Full Text] [Related]
24. Acetylcholine decreases formation of myofibroblasts and excessive extracellular matrix production in an in vitro human corneal fibrosis model.
Słoniecka M; Danielson P
J Cell Mol Med; 2020 Apr; 24(8):4850-4862. PubMed ID: 32176460
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of EZH2 prevents acute respiratory distress syndrome (ARDS)-associated pulmonary fibrosis by regulating the macrophage polarization phenotype.
Bao X; Liu X; Liu N; Zhuang S; Yang Q; Ren H; Zhao D; Bai J; Zhou X; Tang L
Respir Res; 2021 Jul; 22(1):194. PubMed ID: 34217280
[TBL] [Abstract][Full Text] [Related]
26. Proteasomal Degradation of Enhancer of Zeste Homologue 2 in Cholangiocytes Promotes Biliary Fibrosis.
Jalan-Sakrikar N; De Assuncao TM; Shi G; Aseem SO; Chi C; Shah VH; Huebert RC
Hepatology; 2019 Nov; 70(5):1674-1689. PubMed ID: 31070797
[TBL] [Abstract][Full Text] [Related]
27. EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
Gong H; Li Y; Yuan Y; Li W; Zhang H; Zhang Z; Shi R; Liu M; Liu C; Chen C; Liu H; Chen J
BMC Cancer; 2020 Dec; 20(1):1189. PubMed ID: 33276757
[TBL] [Abstract][Full Text] [Related]
28. Smad7 blocks transforming growth factor-β1-induced gingival fibroblast-myofibroblast transition via inhibitory regulation of Smad2 and connective tissue growth factor.
Sobral LM; Montan PF; Zecchin KG; Martelli-Junior H; Vargas PA; Graner E; Coletta RD
J Periodontol; 2011 Apr; 82(4):642-51. PubMed ID: 21054221
[TBL] [Abstract][Full Text] [Related]
29. Role of 5'TG3'-interacting factors (TGIFs) in Vorinostat (HDAC inhibitor)-mediated Corneal Fibrosis Inhibition.
Sharma A; Sinha NR; Siddiqui S; Mohan RR
Mol Vis; 2015; 21():974-84. PubMed ID: 26330748
[TBL] [Abstract][Full Text] [Related]
30. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
[TBL] [Abstract][Full Text] [Related]
31. Corneal chemical burn treatment through a delivery system consisting of TGF-β
Zahir-Jouzdani F; Soleimani M; Mahbod M; Mottaghitalab F; Vakhshite F; Arefian E; Shahhoseini S; Dinarvand R; Atyabi F
Drug Deliv Transl Res; 2018 Oct; 8(5):1127-1138. PubMed ID: 29869292
[TBL] [Abstract][Full Text] [Related]
32. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
[TBL] [Abstract][Full Text] [Related]
33. Effects of arginine vasopressin on differentiation of cardiac fibroblasts into myofibroblasts.
Yan-Hong F; Hui D; Qing P; Lei S; Hai-Chang W; Wei Z; Yan-Jie C
J Cardiovasc Pharmacol; 2010 May; 55(5):489-95. PubMed ID: 20164786
[TBL] [Abstract][Full Text] [Related]
34. miR-145 Is a Promising Therapeutic Target to Prevent Cornea Scarring.
Ratuszny D; Gras C; Bajor A; Börger AK; Pielen A; Börgel M; Framme C; Blasczyk R; Figueiredo C
Hum Gene Ther; 2015 Oct; 26(10):698-707. PubMed ID: 26165705
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts.
Cho JS; Moon YM; Park IH; Um JY; Moon JH; Park SJ; Lee SH; Kang HJ; Lee HM
Clin Exp Allergy; 2012 Jun; 42(6):872-82. PubMed ID: 22239687
[TBL] [Abstract][Full Text] [Related]
36. A PPAR-Gamma Agonist Rosiglitazone Suppresses Fibrotic Response in Human Pterygium Fibroblasts by Modulating the p38 MAPK Pathway.
Nuwormegbe SA; Sohn JH; Kim SW
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5217-5226. PubMed ID: 29049722
[TBL] [Abstract][Full Text] [Related]
37. Phosphodiesterase Type 5 Inhibitors and Selective Estrogen Receptor Modulators Can Prevent But Not Reverse Myofibroblast Transformation in Peyronie's Disease.
Ilg MM; Stafford SJ; Mateus M; Bustin SA; Carpenter MJ; Muneer A; Bivalacqua TJ; Ralph DJ; Cellek S
J Sex Med; 2020 Oct; 17(10):1848-1864. PubMed ID: 32771352
[TBL] [Abstract][Full Text] [Related]
38. Andrographolide Inhibits Corneal Fibroblast to Myofibroblast Differentiation
Rozo V; Quan M; Aung T; Kang J; Thomasy SM; Leonard BC
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291655
[TBL] [Abstract][Full Text] [Related]
39. Limb-bud and Heart (LBH) mediates proliferation, fibroblast-to-myofibroblast transition and EMT-like processes in cardiac fibroblasts.
Wu A; Zhang L; Chen J; Li H; Yang P; Chen M; Liu Q
Mol Cell Biochem; 2021 Jul; 476(7):2685-2701. PubMed ID: 33666830
[TBL] [Abstract][Full Text] [Related]
40. Nintedanib inhibits TGF-β-induced myofibroblast transdifferentiation in human Tenon's fibroblasts.
Lin X; Wen J; Liu R; Gao W; Qu B; Yu M
Mol Vis; 2018; 24():789-800. PubMed ID: 30636861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
